IU Center for Bioethics faculty are exploring various aspects of personalized medicine, including genetic testing and more.
Pilot Study of Individuals’ Responses to Hypothetical Information about Lifetime Risk of Colorectal Cancer (PI: Peter Schwartz)
Patients’ Opinions and Responses to the National Cancer Institute’s Colorectal Cancer Risk Assessment Tool (PI: Peter Schwartz, Tom Imperiale)
A Pilot Study of Providing Patients with Personalized Risk Information Regarding Colorectal Cancer Screening (PI: Peter Schwartz)
Bioethics Program in Predictive Health Ethics Research, Richard M. Fairbanks Foundation, PI: Eric M. Meslin, Investigators: Kimberly A. Quaid, Peter H. Schwartz
Chen JY, Xu H, Shi P, Culbertson A, Meslin EM. Ethics and privacy considerations for systems biology applications in predictive and personalized medicine. In Liu LA, Wei D, Li Yixue, Lei H, editors. Handbook of Research on Computational and Systems Biology: Interdisciplinary Applications. Hershey, PA: IGI Global, 2011. P. 1-27.
Meslin EM, Cho MK. Research ethics in the era of personalized medicine: updating science’s contract with society. Public Health Genomics. 2010;13(6):378-84. Epub 2010 Aug 31. PubMed PMID: 20805701.
Zimmern RL; Ickworth Group. Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genet Med. 2010 Dec;12(12):785-91. PubMed PMID: 21189494.
Schwartz PH. The value of information and the ethics of personal-genomic screening. [Open Peer Commentary] American Journal of Bioethics 2009; 9(4): 26-27.
Barrett PR, Meslin EM, Schwartz PR, Girod J, Odell JD, Quaid K, Wolf J. Report from the PredictER Expert Panel Meeting, November 2, 2007. Indiana University Center for Bioethics. January, 2008. http://hdl.handle.net/1805/1711